Utama › Penyakit Parkinson › Washington
Kajian klinikal Penyakit Parkinson di Washington
15 kajian untuk Penyakit Parkinson sedang mencari peserta di lokasi di Washington.
Bandar di Washington
Teks kajian rasmi (Bahasa Inggeris)
A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's Disease
- EvergreenHealth, Kirkland
- Inland Northwest Research, Spokane
Mengambil pesertaFasa 2
Umur 40 hingga 80 · Semua jantina · Dikemas kini 2 Okt 2026 · NCT06680830A Study to Determine if BHV-8000 is Effective, Safe and Tolerable as a Treatment for Adults Living With Early Parkinson's Disease
- Site-007, Bellevue
- Site-019, Seattle
Mengambil pesertaFasa 2/3
Umur 40 hingga 80 · Semua jantina · Dikemas kini 28 Sep 2026 · NCT06976268A Study of Buntanetap in Participants With PD
- Inland Northwest Research, Spokane
Mengambil pesertaFasa 2/3
Umur 40 hingga 85 · Semua jantina · Dikemas kini 21 Sep 2026 · NCT07284784Low-dose Carbon Monoxide (HBI-002) Trial to Evaluate Safety, Tolerability, PK, and Biomarkers in Parkinson's Disease
- Inland Northwest Research, Spokane
Mengambil pesertaFasa 2
Umur 40 hingga 80 · Semua jantina · Dikemas kini 21 Sep 2026 · NCT07005180Registry of Deep Brain Stimulation With the VERCISE™ System: Vercise DBS Registry
- Evergreen Health, Kirkland
- Virginia Mason Medical Center, Seattle
- University of Washington Medical Center, Seattle
- dan 1 lagi
Mengambil pesertaKajian pemerhatian
Umur 18 ke atas · Semua jantina · Dikemas kini 16 Sep 2026 · NCT02071134A Study to Evaluate the Efficacy, PK, Safety, and Tolerability of VIM0423 in Adults With Parkinson's Disease Tremor Insufficiently Responsive to Dopaminergic Therapy
- Vima Site #023, Kirkland
- Vima Site #015, Spokane
Mengambil pesertaFasa 2
Umur 18 hingga 65 · Semua jantina · Dikemas kini 11 Sep 2026 · NCT07804615A Study to Evaluate the Effectiveness of Two Doses of AP-472 as Adjunctive Therapy to Levodopa in Parkinson's Disease (PD) Participants With Motor Fluctuations
- EvergreenHealth (Site #219), Kirkland
Mengambil pesertaFasa 2
Umur 30 hingga 80 · Semua jantina · Dikemas kini 10 Sep 2026 · NCT07432958Parkinson's Foundation PD GENEration Genetic Registry
- Evergreen Health, Kirkland
- Inland Northwest Research, Spokane
Mengambil pesertaKajian pemerhatian
Umur 18 ke atas · Semua jantina · Dikemas kini 8 Sep 2026 · NCT04994015A US Study That Observes How Parkinson's Disease Changes Over Time in Patients Who Still Have Movement Symptoms Despite Taking Parkinson's Medications
- VA Puget Sound Health Care System, Seattle
Mengambil pesertaKajian pemerhatian
Umur 45 hingga 75 · Semua jantina · Dikemas kini 4 Sep 2026 · NCT07330258A Study to Investigate the Efficacy and Safety of Bemdaneprocel in Adults Who Have Parkinson's Disease
- EvergreenHealth - Research Department, Kirkland
Mengambil pesertaFasa 3
Umur 45 hingga 75 · Semua jantina · Dikemas kini 4 Ogo 2026 · NCT06944522PPMI Clinical - Establishing a Deeply Phenotyped PD Cohort
- Univ of Washington and VA Puget Sound Health Care System, Seattle
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
Umur 30 ke atas · Semua jantina · Dikemas kini 27 Jul 2026 · NCT04477785Use of CereGate Therapy for Freezing of Gait in PD
- University of Washington, Seattle
Mengambil peserta
Umur 21 hingga 80 · Semua jantina · Dikemas kini 28 Mei 2026 · NCT05292794A Study of LY4006896 in Healthy Participants and Participants With Parkinson's Disease
- Evergreen Health Research, Kirkland
- Inland Northwest Research, Spokane
Mengambil pesertaFasa 1Sukarelawan sihat dialu-alukan
Umur 30 hingga 85 · Semua jantina · Dikemas kini 20 Apr 2026 · NCT06809400The Parkinson's Genetic Research Study
- VA Puget Sound Health Care System, Seattle
- University of Washington, Seattle
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
Umur 18 ke atas · Semua jantina · Dikemas kini 14 Mei 2024 · NCT01558479Modifiable Variables in Parkinsonism (MVP)
- Bastyr University, Kenmore
Mengambil pesertaKajian pemerhatian
Umur 19 ke atas · Semua jantina · Dikemas kini 25 Mac 2022 · NCT02194816Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.